Octreotide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00104 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 98 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | vulvar inverted follicular keratosis | KG + DL |
| 2 | seborrheic keratosis | KG + DL |
| 3 | nephrotic syndrome ocular anomalies | KG + DL |
| 4 | Addison disease | KG + DL |
| 5 | membranoproliferative glomerulonephritis, X-linked | KG + DL |
| 6 | familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis | KG + DL |
| 7 | familial idiopathic steroid-resistant nephrotic syndrome with minimal changes | KG + DL |
| 8 | adrenocortical insufficiency | KG + DL |
| 9 | primary hypereosinophilic syndrome | KG + DL |
| 10 | autosomal recessive familial Mediterranean fever | KG + DL |
| 11 | primary hereditary glaucoma | KG + DL |
| 12 | secondary hypereosinophilic syndrome | KG + DL |
| 13 | familial nephrotic syndrome | KG + DL |
| 14 | open-angle glaucoma | KG + DL |
| 15 | familial Mediterranean fever, autosomal dominant | KG + DL |
| 16 | retinal telangiectasia | KG + DL |
| 17 | renal-hepatic-pancreatic dysplasia | KG + DL |
| 18 | Smouldering systemic mastocytosis | KG + DL |
| 19 | gout | KG + DL |
| 20 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 21 | dermatofibrosarcoma protuberans | KG + DL |
| 22 | arteriosclerotic retinopathy | KG + DL |
| 23 | retinal microaneurysm | KG + DL |
| 24 | 46,XY disorder of sex development | KG + DL |
| 25 | vertebral artery occlusion | KG + DL |
| 26 | retinal artery occlusion | KG + DL |
| 27 | karyomegalic interstitial nephritis | KG + DL |
| 28 | humoral hypercalcemia of malignancy | KG + DL |
| 29 | Joubert syndrome with renal defect | KG + DL |
| 30 | polycystic kidney disease 3 with or without polycystic liver disease | KG + DL |
| 31 | eosinophilic pneumonia | KG + DL |
| 32 | thoracic malformation | KG + DL |
| 33 | chronic tic disorder | KG + DL |
| 34 | systemic mastocytosis | KG + DL |
| 35 | steroid-resistant nephrotic syndrome | KG + DL |
| 36 | psychogenic movement disorders | KG + DL |
| 37 | benign shuddering attacks | KG + DL |
| 38 | extrapyramidal and movement disease | KG + DL |
| 39 | adult familial nephronophthisis-spastic quadriparesia syndrome | KG + DL |
| 40 | Plasmodium falciparum malaria | KG + DL |
| 41 | primary orthostatic tremor | KG + DL |
| 42 | glaucoma 1, open angle | KG + DL |
| 43 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 44 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 45 | inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | KG + DL |
| 46 | Pierson syndrome | KG + DL |
| 47 | Congenital adrenal insuffiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | KG + DL |
| 48 | subarachnoid hemorrhage (disease) | KG + DL |
| 49 | fibroma of prostate | KG + DL |
| 50 | adrenomyodystrophy | KG + DL |
(Showing top 50 of 98 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.